Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

July 9, 2026 updated by: Ali Mohamed Ali ismail, Cairo University
metabolci syndrom is highly prevalent in behcet disorder females. usually physical activity is recommended to solve this problem

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

metabolci syndrom-fenales with behcet disorder (n=40) were assigned to group I or group II. Group I will perform treadmill walk for 40 minutes. group II will act as waitlist. the group will contian 20 females

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Egypt
    • Dokki
      • Giza, Dokki, Egypt
        • Recruiting
        • Cairo University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • females with metabolci syndrome
  • females with behcet disorder

Exclusion Criteria:

  • psychatric diseases women
  • mental diseased women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group I
metabolci syndrom-fenales with behcet disorderallocated to Group I (n=20) will perform treadmill walk for 40 minutes.
Behavioral: treadmill walking
metabolci syndrom-females with behcet disorder assigned to group I (n=20) will perform treadmill walk for 40 minutes, thrice weekly, for 12 weeks
No Intervention: group II
metabolci syndrom-females with behcet disorder (n=20) allocated to Group II (n=20) will act as waitlist group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
high density lipoprotin
Time Frame: it will be asessed after 12 weeks
it is a lipid profile component
it will be asessed after 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
triglycrides
Time Frame: It will be assessed after 12 weeks
it is a lipid profile component
It will be assessed after 12 weeks
body mass index
Time Frame: It will be assessed after 12 weeks
it will be assessed on empty stomach
It will be assessed after 12 weeks
waist circumfrence
Time Frame: It will be assessed after 12 weeks
it will be assessed with inelsatic tape
It will be assessed after 12 weeks
fasting blood glucoses
Time Frame: It will be assessed after 12 weeks
it will be assessed in plasma
It will be assessed after 12 weeks
systolic blood presssure
Time Frame: It will be assessed after 12 weeks
it will be assessed at brachial artery
It will be assessed after 12 weeks
diastolci blood pressure
Time Frame: It will be assessed after 12 weeks
it will be assessed at brachial artery
It will be assessed after 12 weeks
subjective vitality scale
Time Frame: It will be assessed after 12 weeks
A questionaire will assess vitality of subjects
It will be assessed after 12 weeks
satifaction with life scale
Time Frame: It will be assessed after 12 weeks
A questionsire will assess satisfaction with life
It will be assessed after 12 weeks
ptisburg sleep quality index
Time Frame: It will be assessed after 12 weeks
A questionsire will assess sleep level
It will be assessed after 12 weeks
fatigue severity scale
Time Frame: It will be assessed after 12 weeks
A questionsire will assess fatigue level
It will be assessed after 12 weeks
Behcet disease -related life quality questionaire
Time Frame: It will be assessed after 12 weeks
A questionsire will assess life quality
It will be assessed after 12 weeks
ruffier index
Time Frame: It will be assessed after 12 weeks
it will assess fitness of cardiopulmoanry system
It will be assessed after 12 weeks
Hamilton anxiety rating scale
Time Frame: It will be assessed after 12 weeks
A questionsire will assess anxiety
It will be assessed after 12 weeks
Hamilton depression scale
Time Frame: It will be assessed after 12 weeks
A questionsire will assess depression
It will be assessed after 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Principal Investigator: Ali MA Ismail, lecturer, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 2, 2026

Primary Completion (Estimated)

September 14, 2026

Study Completion (Estimated)

September 14, 2026

Study Registration Dates

First Submitted

July 9, 2026

First Submitted That Met QC Criteria

July 9, 2026

First Posted (Actual)

July 14, 2026

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 9, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB000-14233-86

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on treadmill walking

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe